1. Home
  2. SCNI vs AIHS Comparison

SCNI vs AIHS Comparison

Compare SCNI & AIHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCNI
  • AIHS
  • Stock Information
  • Founded
  • SCNI 2003
  • AIHS 2014
  • Country
  • SCNI Israel
  • AIHS China
  • Employees
  • SCNI N/A
  • AIHS 35
  • Industry
  • SCNI Biotechnology: Biological Products (No Diagnostic Substances)
  • AIHS Finance: Consumer Services
  • Sector
  • SCNI Health Care
  • AIHS Finance
  • Exchange
  • SCNI Nasdaq
  • AIHS Nasdaq
  • Market Cap
  • SCNI 4.6M
  • AIHS 5.1M
  • IPO Year
  • SCNI N/A
  • AIHS 2018
  • Fundamental
  • Price
  • SCNI $0.89
  • AIHS $1.09
  • Analyst Decision
  • SCNI
  • AIHS
  • Analyst Count
  • SCNI 0
  • AIHS 0
  • Target Price
  • SCNI N/A
  • AIHS N/A
  • AVG Volume (30 Days)
  • SCNI 53.1K
  • AIHS 51.0K
  • Earning Date
  • SCNI 11-24-2025
  • AIHS 11-19-2025
  • Dividend Yield
  • SCNI N/A
  • AIHS N/A
  • EPS Growth
  • SCNI N/A
  • AIHS N/A
  • EPS
  • SCNI 0.26
  • AIHS N/A
  • Revenue
  • SCNI $1,147,000.00
  • AIHS $3,560,626.00
  • Revenue This Year
  • SCNI N/A
  • AIHS N/A
  • Revenue Next Year
  • SCNI N/A
  • AIHS N/A
  • P/E Ratio
  • SCNI $3.30
  • AIHS N/A
  • Revenue Growth
  • SCNI 303.87
  • AIHS N/A
  • 52 Week Low
  • SCNI $0.86
  • AIHS $0.83
  • 52 Week High
  • SCNI $6.18
  • AIHS $17.00
  • Technical
  • Relative Strength Index (RSI)
  • SCNI 30.08
  • AIHS 28.17
  • Support Level
  • SCNI $0.86
  • AIHS $1.00
  • Resistance Level
  • SCNI $1.04
  • AIHS $1.18
  • Average True Range (ATR)
  • SCNI 0.08
  • AIHS 0.12
  • MACD
  • SCNI -0.01
  • AIHS -0.01
  • Stochastic Oscillator
  • SCNI 9.07
  • AIHS 34.40

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

About AIHS Senmiao Technology Limited

Senmiao Technology Ltd is a holding company. Along with its subsidiaries, it is engaged in facilitating automobile transactions and offering related services. The group's business activities include providing car rental services to individual customers with lease term no more than twelve months; leasing and servicing of new energy vehicles; offering services to automobile purchasers throughout the purchase process; providing management and related services to Partner Platforms and other companies; automobile financing; and providing other related supporting services to customers. The majority of the group's revenue is generated from its automobile rental business.

Share on Social Networks: